Search
By Very International People - 2 days ago
ESPORTSTRAVEL SUMMIT RESCHEDULES TO DECEMBER 14-16
Northstar Meetings Group has announced that the 2021 EsportsTravel Summit -the only event of its kind for esports tournament and event...
Travel, Traveling, Entertainment, Destinations, Business, Event, Esports, Main Feature, ASM Global, Atlantic City Sports Commission, CSL, Dallas Sports Commission, David L. Lawrence Convention Center, Daytona Beach Area Convention & Visitors Bureau, esports, eSportsTravel Summit, Jennifer Hawkins, Northstar Meetings Group, Populous, Snohomish County Sports Commission, SportsPittsburgh, SportsTravel Magazine, TEAMS Conference, Timothy Schneider, TripMate, Tyler Othen, Visit Anaheim
More
By Master Doctor - 14 days ago
HOW AUSTRALIA IS MAKING THE ASTRAZENECA VACCINE
The first batch of the vaccine that will bring us a step closer to ending the COVID-19 pandemic is sitting in a freezer at CSL's Parkville...
By VIP Net - 2 monthes ago
NEW RESEARCH SHOWS ESPORTS FANS WANT TO TRAVEL POST-COVID
The number of esports fans has skyrocketed during the coronavirus pandemic and those fans will be more willing than the general public...
By Biotech Mag - 3 monthes ago
GENE THERAPY HEMOPHILIA B ‘CURE' APPROACH HEATS UP AS UNIQURE/CSL, RIVALLING PFIZER, SHOWS PROMISE
Gene therapy hemophilia B ‘cure' approach heats up as uniQure/CSL, rivalling Pfizer, shows promise badams Thu, 11/19/2020 - 10:38
By Biotech Mag Top - 6 monthes ago
J&J BOOSTS AUTOIMMUNE DISEASE DRUG PIPELINE WITH $6.5B MOMENTA BUYOUT
Johnson & Johnson is acquiring Momenta Pharmaceuticals in a $6.5 billion deal that brings the pharma giant a slate of experimental...
Therapies, Clinical, BioTech, Biotech, Pharmaceuticals, Pharmaceutical, Immunity, Drug, Drugs, Pharma, Boston blog main, Boston top stories, National blog main, National top stories, New York, New York blog main, New York top stories, Alexion Pharmaceuticals, Argenx, Autoimmune Diseases, chronic inflammatory demyelinating polyneuropathy, clinical trials, CSL Limited, deals, efgartigimod, generalized myasthenia gravis, hemolytic disease of the fetus and newborn, immune thrombocytopenic purpura, Janssen Pharmaceutical, Johnson & Johnson, Life Sciences, Momenta Pharmaceuticals, National Organization for Rare Disorders, nipocalimab, pemphigus vulgaris, Psoriasis, psoriatic arthritis, rozanolixizumab, Syntimmune, UCB, ustekinumab, Virdante Pharmaceuticals, warm autoimmune hemolytic anemia
More
By Biotech Mag Top - 7 monthes ago
FREELINE THERAPEUTICS AND CHECKMATE PHARMA MAKE OPENING IPO MOVES
The biotech IPO queue has added two more companies. Freeline Therapeutics and Checkmate Pharmaceuticals have each filed the regulatory...
Therapies, Gene, Genetics, BioTech, Biotech, Pharmaceuticals, Pharmaceutical, Gene Therapy, Pharma, Genes, NASDAQ, Therapeutics, Boston blog main, Boston top stories, Europe, Europe blog main, Europe top stories, National blog main, National top stories, Amit Nathwani, Art Krieg, BioMarin Pharmaceuticals, Biotech IPOs, Bristol-myers Squibb, cancer immunotherapy, Checkmate Pharmaceuticals, checkpoint inhibitor, clinical trials, CSL Behring, Fabry Disease, FDA, Freeline Therapeutics, Gaucher disease, hemophilia A, hemophilia B, Immunotherapy, International Society on Thrombosis and Haemostasis, investing, Life Sciences, Melanoma, Merck, Nivolumab, Novo Holdings, pembrolizumab, Sofinnova Venture Partners, Syncona, uniQure, University College London, VenBio
More
By Biotech Mag Top - 7 monthes ago
BIO ROUNDUP: GILEAD'S PIONYR GRAB, RELAY TO IPO, UNICORN SANA & MORE
Uncertainty related to the continued spread of the pandemic continued to consume most of the oxygen in the room this week, but life...
Research, Healthcare, Science, Biotech, Life Sciences, BioTech, Boston blog main, Boulder, Denver blog main, Detroit blog main, Europe blog main, Indiana blog main, National, National blog main, National top stories, New York blog main, Philadelphia Blog Main, Raleigh-Durham blog main, San Diego blog main, San Francisco blog main, Seattle blog main, Texas blog main, Wisconsin blog main, Aegerion Pharmaceuticals, Akili Interactive, Akouos, Allen Melemed, Amryt Pharma, ArcherDx, AsclepiX Therapeutics, BioGeneration Ventures, BioHaven Pharmaceuticals, BioXcel, Bob Radie, Catalent, Century Therapeutics, Chimerix, Codiak BioSciences, Compass Therapeutics, COVID-19, COVID-19 vaccine, CSL Behring, Empirica Therapeutics, Enterome, FDA, fenfluramine, Fibrogen, Gilead Sciences, Illumina, InVitae, Jason Fontenot, Josefin-Beate Holz, Karyopharm Therapeutics, La Jolla Pharmaceutical, Melinta Therapeutics, Merck, ModeRNA, Nabriva Therapeutics, Neuraptive Therapeutics, Nkarta, Olivia Ventures, Pionyr Immunotherapeutics, Poseida Therapeutics, Regeneron Pharmaceuticals, Reina Benabou, Relay Therapeutics, Renalytix AI, Reneo Pharmaceuticals, Sana Biotechnology, Sangamo Therapeutics, Sanofi, Sarepta Therapeutics, seres Therapeutics, Simcha Therapeutics, Storm Therapeutics, Terri Young, Tetraphase Pharmaceuticals, Thane Wettig, Translate Bio, troriluzole, uniQure, Yumanity Therapeutics, Zogenix
More
By Biotech Mag Top - 7 monthes ago
CSL BEHRING BOLSTERS HEMOPHILIA LINEUP WITH DEAL FOR UNIQURE'S GENE THERAPY
CSL Behring is joining the chase for a genetic treatment for hemophilia by acquiring a uniQure gene therapy that's already in late-stage...
Therapies, Genetics, Gene Therapy, Gene, Genes, Boston blog main, Boston top stories, National blog main, National top stories, New York blog main, Philadelphia, Philadelphia Blog Main, Philadelphia Top stories, San Francisco blog main, San Francisco top stories, American Society of Hematology, BioMarin Pharmaceutical, Biotech, clinical trials, CSL Behring, CSL Limited, entranacogene dezaparvovec, FDA, giroctocogene fitelparvovec, hemophilia A, hemophilia B, Life Sciences, Pfizer, Rare diseases, Sangamo Therapeutics, uniQure, Valoctocogene roxaparvovec
More
By Biotech Mag - 8 monthes ago
CSL TO PAY $450M TO BUY UNIQURE'S HEMOPHILIA B GENE THERAPY
CSL to pay $450M to buy uniQure's hemophilia B gene therapy ntaylor Thu, 06/25/2020 - 04:43
By Biotech Mag - 8 monthes ago
BIO ROUNDUP: A ROYAL IPO, AKILI ARRIVES, ORCA BIO SURFACES & MORE
The biggest life sciences deal this week involves a company that doesn't discover or develop drugs, or even sell them. Yet its mark...
Science, BioTech, Life Sciences, Biotech, Pharmaceuticals, Pharmaceutical, Drug, Drugs, Medicine, Pharma, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Europe blog main, Europe top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Philadelphia Blog Main, Philadelphia Top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, 4D Molecular Therapeutics, AbbVie, Akili Interactive, Allergan, Alpine Immune Sciences, Assembly Biosciences, avalglucosidase alfa, Biogen, Biotech IPOs, Bit Bio, Blackstone, Burosumab, C4 Therapeutics, cancer immunotherapy, chloroquine, clinical trials, COVID-19, CSL, CureVac, deals, dexamethasone, dimethyl fumarate, Engrail Therapeutics, Enzyme Replacement Therapies, epithelioid sarcoma, Epizyme, follicular lymphoma, FORMA Therapeutics, Frazier Healthcare Partners, GlaxoSmithKline, hydroxychloroquine, Ideaya Biosciences, inebilizumab, Inflammatory Bowel Disease, investing, IPO, Jazz Pharmaceuticals, Lassen Therapeutics, Liver Disease, lurbinectedin, Medtronic, Merck, Mylan, Nan Fung Life Sciences, Neurocrine Bio, Neuroscience, nonalcoholic steatohepatitis, NovaVax, Ocuphire Pharma, Orca Bio, osteomalacia, Oxford University, Pacific Biosciences, pembrolizumab Keytruda, PharmaMar, Pompe disease, Progenity, Proteus Digital Health, RA Capital, Regenerative Medicine, Repare Therapeutics, Rexahn Pharmaceuticals, Royalty Pharma, Sagimet Biosciences, Sanofi, small cell lung cancer, startups, Surrozen, Synthetic Biology, Takeda Pharmaceutical, tazemetostat, Ultragenyx Pharmaceutical, vaccines, Viela Bio, X-linked hypophosphatemia
More
By Biotech Mag - 8 monthes ago
FRAZIER LAUNCHES LASSEN TO ADVANCE ANTIBODIES AGAINST FIBROSIS, CANCER
Lassen Therapeutics, a biotech that is developing antibodies as potential treatments for fibrosis, rare diseases, and cancer, debuted...
Drugs, Healthcare, Drug, Therapeutics, Rare Diseases, Biotech, BioTech, Cancer, Clinical, Boston blog main, National blog main, San Diego, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Alta Partners, AnaptysBio, Andrew Nash, Antibody Drugs, aTyr Pharma, Bristol-myers Squibb, cancer, CSL, David King, deals, Fibrosis, Financing, Frazier Healthcare Partners, funding, IL-11, Lassen Therapeutics, Life Sciences, Longwood Fund, Mark Barrett, Medarex, startups, Venture Capital
More
By Sportyst Usa - 2 years ago
FOOTBALL: CSL: SHANGHAI SIPG MOVE BACK TO TOP AFTER SHANDONG LUNENG WIN
Shanghai SIPG moved back to the top of the Chinese Super League, after a convincing 4-2 win over third-placed Shandong Luneng on Sunday.
By Auto Motor Buzz - 2 years ago
BMW M2 CS OR CSL SPOTTED TESTING AT THE NÜRBURGRING
A large amount of new spy shots shows us that BMW are currently evaluating an even hotter M2 variant with earlier rumors suggesting...
Test, Competition, Car, BMW, New, Parts, Show, Performance, News
More
By Biotech Mag Top - 2 years ago
BIO ROUNDUP: EPIPEN SHORTAGE, BLUEBIRD'S BET, BIOTECH IPOS & MORE
It's back-to-school season and that means it's time to load up on school supplies. For many students and schools, one crucial item...
Food, Pharmaceutical, Biotech, BioTech, Manufacturing, Pharmaceuticals, Boston blog main, Boston top stories, Boulder, Denver blog main, Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories, AbbVie, Allergan, ApoGen Biotechnologies, BioNano Genomics, BlueBird Bio, Bristo-Myers Squibb, cenegermin, Chemotherapy, CSL, CSweetener, deals, Dompe Pharmaceutical, Donald Trump, Entasis therapeutics, EpiPen, Exact Sciences, FDA, Food and Drug Administration, GE Ventures, Gilead Sciences, Gritstone Oncology, Hereditary Angiodema, Immunotherapy, influenza, investing, IPOs, Koch Institute, lanadelumab, Life Sciences, Lisa Suennen, Mallinckrodt, Merck, Merck KGaA, MIT, Modern Healthcare, momelitinib, myelofibrosis, Mylan, neurotrophic keratitis, nivolulmab, pembrolizumab, Pfizer, Principia Biopharma, Rakuten Aspyrian, Rare diseases, RDMD, Renovia, Seqirus, Shire, Sierra Oncology, small cell lung cancer, stannsoporfin, startups, Susan Hockfield, Teva Pharmaceutical, TraceLink, ulipristal acetate, Vaccine
More
By Cars Mag - 2 years ago
DODGE CHALLENGER REDEYE PRICING, BMW M4 CSL SPY SHOTS, ORIGINAL FORD BRONCO RIDES AGAIN: TODAY'S CAR NEWS
Last week we learned that Dodge isn't just letting those Challenger SRT Demon parts go to waste. A Challenger Hellcat Redeye model...
Pages
We are sorry, there is no page for your query.